Does BPC-157 Grow New Blood Vessels to Help Injuries Heal?

In animal and cell studies, BPC-157 helped injured muscle and tendon rebuild their blood supply. It did this by raising VEGFR2, a receptor that blood-vessel cells use to respond to growth signals, and by switching on the nitric oxide pathway involved in vessel growth (VEGFR2 study in rats and human cells). BPC-157 seemed to work where tissue was healing rather than on its own. In one study it had no direct effect on vessel cells in a dish (muscle and tendon healing study).

Human studies are small, and none has tested BPC-157 for everyday workout recovery. Its clearest case is a specific injury that is slow to heal, like a tendon that still aches months after you hurt it.

How does BPC-157 grow new blood vessels in injured tissue?

BPC-157 helps injured tissue rebuild its blood supply by turning up the signals that vessel cells already use to grow. In rats with blocked blood flow to a hind leg, BPC-157 brought blood flow back faster and increased the number of blood vessels in the leg muscle (VEGFR2 study).

The same research looked at human blood-vessel cells. BPC-157 raised VEGFR2, the receptor that lets these cells respond to growth signals. It did not raise VEGF-A, the growth signal itself. It also switched on a chain of signals: VEGFR2, then Akt, then eNOS, the enzyme that makes nitric oxide. When researchers stopped cells from pulling that receptor inside, BPC-157's boost to vessel-like tube formation was blocked.

The setting mattered. In one study, BPC-157 had no direct vessel-growing effect on cells in a dish. In animals with crushed muscle or cut muscle and tendon, the healing tissue showed well-regulated vessel growth, raised VEGF and better healing (muscle and tendon healing study).

The effect also depended on the tissue. In animal studies, BPC-157 helped the cornea heal without new vessels growing into it (2025 review of BPC-157 for musculoskeletal healing). That is why researchers say it "modulates" vessel growth. It does not grow vessels everywhere.

Why does blood flow matter so much for tendon and ligament injuries?

Tendons, ligaments and the spot where muscle meets tendon have a poor blood supply, which is part of why they heal slowly. Animal studies found BPC-157's blood-vessel effects especially in these tissues. The muscle-tendon junction is usually a weak spot, and BPC-157 clearly improved its healing in animals (2025 review).

In animal injury models, BPC-157 improved how injured tendon, ligament, muscle and bone healed. Researchers measured the tissue's structure, its strength and how well it worked (2025 systematic review in orthopaedic sports medicine).

In animals, BPC-157 also helped tendon heal back onto bone when steroids were given, and steroids normally slow healing (2025 review). If you have had steroid shots for a nagging tendon, this result is relevant to you.

Timing matters too. Injury healing runs in three phases: inflammation (days 1 to 5), repair (days 5 to 14) and remodeling (day 14 to 90 and beyond). A tendon problem plays out over weeks to months, not days.

Has BPC-157 been tested for workout recovery in people?

Not for everyday workout recovery. The human research so far covers knee pain, bladder pain and safety, in small groups.

On r/Peptides, a 30-year-old man with years of shoulder pain said he had already tried physical therapy. He wrote: "By week two, I was going about my day and suddenly realized the shoulder didn't hurt." At the end of his run he said: "Finished that 40-day run and I'd say about 60–70% of the pain had vanished, though I still had the odd bad morning." That is one man's shoulder, with most of the pain gone and some bad mornings left.

The blood-vessel effect points to one injury that will not settle, like a sore tendon or a tweaked shoulder. It does not point to general soreness after leg day. Keep doing your rehab exercises alongside any treatment.

Is boosting blood vessel growth with BPC-157 safe?

The main question researchers raise is cancer. Tumors also rely on new blood vessels, and BPC-157 raises VEGF, eNOS and EGR-1, all signals involved in vessel growth. Other lab work found BPC-157 held back uncontrolled cell growth and worked against VEGF-driven tumor growth (2025 review). If you have a history of cancer, tell your clinical team before starting.

Animal safety studies in rats and dogs found no organ damage and no toxic dose over up to six weeks. No study looked past six weeks, and the systematic review found no study that measured BPC-157's safety in humans (2025 systematic review).

The FDA says compounded BPC-157 may trigger an immune reaction for certain ways of taking it and can carry impurities from how the peptide is made. The agency also says it lacks enough information to know whether BPC-157 would cause harm in humans. Ask your clinical team what to watch for.

Where your BPC-157 comes from matters. Products sold online as a "research chemical" or supplement are not checked for quality or safety. Between 12% and 58% of sports-nutrition supplements have been found contaminated with other, often unsafe, substances (2025 systematic review). That is one reason to go through a clinical team and a licensed pharmacy rather than a grey-market vial.

If you compete in a drug-tested sport, BPC-157 is banned in professional sports. Its half-life is under 30 minutes, meaning half of a dose is broken down in that time, but testing can detect it in urine for up to 4 days.

Can you get BPC-157 prescribed, and what does it cost?

BPC-157 has no FDA-approved use (2025 systematic review). It is made by compounding pharmacies, which prepare medications for individual patients.

Compounding pharmacies can only use certain ingredients, and the 503A bulks list is one route for an ingredient to qualify. For its July 23, 2026 advisory committee meeting, the FDA proposed that BPC-157 not be included on that list. The FDA says it will not make a final decision until the advisory committee's input has been considered and all reviews are finished.

Across the peptide-focused telehealth providers tracked, compounded BPC-157 programs run from $165 to $368 a month, with a median of $197. Those prices assume about 5 mg a month on a typical vial-based program.

Our clinical team can tell you whether BPC-157 fits your injury and your plan, and how it would work with the rest of your recovery. If a sore tendon or shoulder is cutting your workouts short, take the quiz so your clinical team can see whether BPC-157 fits your injury and your plan.